- Home
- Companies
- north america
- cancer common but preventable
Show results for
Refine by
Cancer Common But Preventable Suppliers In North America
9 companies found
based inSuffern, NEW YORK (USA)
An advanced diagnostic platform that leverages artificial intelligence (AI) enabled tissue analysis and 3D imaging to reliably detect precancerous cells. CDx provides an integrated solution of enhanced tissue sampling and an AI-assisted diagnostic ...
Provides physicians with a practical method of testing non-suspicious tissue in order to help prevent laryngeal cancer. Otolaryngologists are often faced with a dilemma when relatively non-suspicious tissue is observed in the office during flexible ...
based inWest Vancouver, BRITISH COLUMBIA (CANADA)
Focusing initially on breast cancer, BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) is dedicated to enhancing the lives of people with cancer with limited therapy options by developing novel immunotherapies to fight cancer. ...
based in, CALIFORNIA (USA)
AIVITA Biomedical is a biotechnology company developing personalized vaccines that target COVID-19 and the seed of all cancers using our autologous cell platform. We leverage our unique expertise in stem cell growth and directed, high-purity ...
based inPhoenix, ARIZONA (USA)
VisionGate, Inc., is a breakthrough liquid-biopsy technology company, leading the battle against lung cancer through early detection technology with a simple, non-intrusive sputum test. The foundation for our diagnostics capability is the ...
based inMountain View, CALIFORNIA (USA)
iPSCs- a revolutionary discovery with untapped potential. We are dedicated to revolutionizing medical treatment and prevention of cancer and other diseases by harnessing the unlimited immunotherapeutic potential of induced pluripotent stem cells ...
based inGeorgetown, TEXAS (USA)
Ezra is focused on early cancer detection through the use of full-body MRI scans. Given that early detection significantly increases survival rates, Ezra's annual Full Body Scans aim to identify cancer signs early, potentially preventing late-stage ...
based inHouston, TEXAS (USA)
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) is a public biopharmaceutical company based in the Houston, TX area that is developing GP2, a novel peptide immunotherapy, and has commenced a Phase III clinical trial, called Flamingo-01. GP2 is derived ...
Cancer Immunotherapies are a New Method of Cancer Treatment. Among the more established treatment options, such as surgery, chemotherapy, targeted therapy, and radiation therapy, cancer immunotherapy is a rapidly emerging and important field. It ...
based inSanta Ana, CALIFORNIA (USA)
Aqua Medical has developed a disruptive, vapor-based, endoscopic, ablation technology designed to treat gastrointestinal disease and prevent GI cancers. Aqua Medical’s unique ablation technology consists of high-temperature water vapor created by a ...
based inNew York, NEW YORK (USA)
ENB is developing platform oncology molecules to unlock the full therapeutic potential of immune-based cancer therapies. We are developing small molecules that turn off a common “switch” that activates critical pro-cancer components of the TME: the ...